NCT02396602

Brief Summary

Using our experience in digital media, behavior theory, client-centered interventions, and family planning, we have prototyped a digital application ("app")-miPlan-to be used in the clinic waiting room prior to a contraceptive visit. The goal of this research is to refine the app and conduct a randomized controlled trial of the miPlan intervention vs. standard care. The aim of this study is to understand miPlan's impact. The primary outcome is LARC uptake at clinic discharge. The secondary outcomes are contraceptive use at discharge, self-efficacy and decisional balance for highly effective contraception post-app use, contraceptive satisfaction, and intention to continue method use. The research will consist of baseline activities as well as a three-month follow-up call.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 24, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

August 25, 2016

Status Verified

August 1, 2016

Enrollment Period

1.3 years

First QC Date

February 16, 2015

Last Update Submit

August 24, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • LARC uptake

    uptake of the implant or IUD at time of intervention (measured via contraceptive method choice and delivery by checkbox)

    at time of intervention (baseline (0 weeks)

Secondary Outcomes (5)

  • contraceptive use

    at time of intervention (baseline (0 weeks))

  • change in self-efficacy for contraception at 12 weeks

    baseline (0 weeks) and 12 weeks

  • change in decisional balance for highly effective methods at 12 weeks

    baseline (0 weeks) and 12 weeks

  • contraceptive satisfaction

    12 weeks post-enrollment

  • intention to continue method use

    12 weeks post enrollment

Study Arms (2)

Intervention

EXPERIMENTAL

After completing baseline the baseline questionnaire, women randomized to the intervention group will receive an iPad, along with a brief tutorial on iPad navigation, and use the miPlan app for up to 15 minutes. They will complete a post-intervention survey before proceeding to standard of care contraceptive counseling.

Behavioral: miPlan intervention

Control

NO INTERVENTION

After completing baseline the baseline questionnaire, women randomized to the control arm will proceed to standard of care contraceptive counseling.

Interventions

miPlan mobile contraceptive counseling waiting room app intervention

Intervention

Eligibility Criteria

Age15 Years - 29 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • African American or Latina female and sexually active with a male partner(s) within the past 6 months,
  • age 15 to 29 years
  • present for contraception initiation
  • English speaking

You may not qualify if:

  • not currently pregnant or intending pregnancy within the next 6 months
  • and not currently using LARC
  • not highly intending LARC at enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Planned Parenthood Illinois, Englewood Health Center

Chicago, Illinois, 60636, United States

Location

Related Publications (1)

  • Hebert LE, Hill BJ, Quinn M, Holl JL, Whitaker AK, Gilliam ML. Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: A randomized controlled trial. Contraception. 2018 Oct;98(4):281-287. doi: 10.1016/j.contraception.2018.07.001. Epub 2018 Jul 10.

Study Officials

  • Melissa Gilliam, MD, MPH

    University of Chicago, Dept. of OBGYN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2015

First Posted

March 24, 2015

Study Start

February 1, 2015

Primary Completion

June 1, 2016

Study Completion

August 1, 2016

Last Updated

August 25, 2016

Record last verified: 2016-08

Locations